8-KThe WireRoutine
Reg FD Disclosure
Filed Nov 7, 2024 · 1y ago · Accession 0001104659-24-115355
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRESCENT BIOPHARMA, INC.
- Ticker
- CBIO
- CIK
- 1253689
- Form type
- 8-K
- Filing date
- Nov 7, 2024
- Report date
- Nov 7, 2024
- Document
- tm2427808d1_8k.htm
- Size
- 4.4 MB